Lynch syndrome

Search with Google Search with Bing
Information
Disease name
Lynch syndrome
Disease ID
DOID:3883
Description
"A syndrome that is characterized by an increased risk for colon cancer and cancers of the endometrium, ovary, stomach, small intestine, hepatobiliary tract, urinary tract, brain, and skin and has_material_basis_in mutation of mismatch repair genes that increases the risk of many types of cancers." [url:http\://en.wikipedia.org/wiki/Hereditary_nonpolyposis_colorectal_cancer, url:http\://ghr.nlm.nih.gov/condition/lynch-syndrome]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
MLH1 3 36,993,518 37,050,846 100
MLH1 3 36,993,518 37,050,846 32
MSH2 2 47,403,156 47,483,223 30
MSH6 2 47,783,145 47,806,953 12
FBXO11 2 47,806,920 47,906,498 10
RET 10 43,077,069 43,130,351 10
PRKDC 8 47,773,111 47,960,136 10
PTCH1 9 95,442,980 95,509,266 8
CFTR 7 117,480,025 117,668,665 8
FANCA 16 89,737,549 89,816,647 8
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02912559 Active, not recruiting Phase 3 Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair October 16, 2017 April 2, 2025
NCT00217737 Active, not recruiting Phase 3 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer September 6, 2005 September 30, 2024
NCT03631641 Active, not recruiting Phase 2 Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy August 21, 2018 December 31, 2020
NCT05257057 Active, not recruiting Frequency of Endometrial Cancer Precursors Associated With Lynch Syndrome May 8, 2019 December 2024
NCT02494791 Active, not recruiting N/A Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer July 2015 July 2025
NCT02194387 Active, not recruiting N/A Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members September 17, 2014 September 30, 2025
NCT03831698 Active, not recruiting Phase 2 Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE) February 6, 2019 August 2024
NCT02206360 Active, not recruiting Pancreatic Cancer Early Detection Program April 2014 June 2024
NCT04125914 Active, not recruiting N/A Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families January 26, 2017 April 30, 2026
NCT02371135 Active, not recruiting Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes February 2015 February 2025
NCT03832985 Active, not recruiting Early Phase 1 Pediatric Reporting of Adult-Onset Genomic Results November 25, 2020 June 30, 2024
NCT04145388 Active, not recruiting N/A Family History Study on Cancer Risk July 1, 2020 August 31, 2025
NCT03460483 Active, not recruiting N/A Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care March 30, 2018 June 30, 2023
NCT01823471 Completed N/A I-Scan For Colon Polyp Detection In HNPCC November 2010 June 2013
NCT01845753 Completed Molecular Screening for Lynch Syndrome in Denmark October 2012 December 31, 2019
NCT04131062 Completed N/A Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants November 1, 2019 May 19, 2022
NCT01850654 Completed N/A Ohio Colorectal Cancer Prevention Initiative December 26, 2012 January 2, 2018
NCT00633607 Completed Hereditary Colorectal and Associated Tumor Registry Study April 2012 January 26, 2018
NCT04452266 Completed Predictive Factor Study of the Occurrence of Endometrial Cancer in Patients With Lynch Syndrome August 14, 2020 October 20, 2020
NCT00898768 Completed Early Phase 1 Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch Syndrome May 2009 December 2014
NCT02052908 Completed Phase 1 Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome January 27, 2014 January 5, 2021
NCT02198092 Completed Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes July 2014 August 2019
NCT00905710 Completed N/A Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome September 2008 May 2016
NCT02951390 Completed N/A High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome. July 2016 December 31, 2017
NCT03046849 Completed Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria March 8, 2017 February 26, 2019
NCT03047226 Completed Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer February 28, 2017 July 31, 2018
NCT01216930 Completed Molecular Screening for Lynch Syndrome in Southern Denmark October 2010 September 2015
NCT01582841 Completed N/A Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting February 2012 July 2016
NCT03344289 Completed N/A Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH) January 21, 2018 June 9, 2020
NCT02570516 Completed N/A NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome November 2015 February 2018
NCT02645084 Completed N/A Identifying Patients With Hereditary and Familial Colorectal Cancer by Using an Online Risk Tool February 2015 October 30, 2016
NCT00609505 Completed N/A Telemedicine vs. Face-to-Face Cancer Genetic Counseling August 2008 April 2011
NCT04197856 Enrolling by invitation N/A Direct Information to At-risk Relatives February 6, 2020 December 31, 2025
NCT06126120 Enrolling by invitation Colonoscopy Check-up in People With Lynch Syndrome January 17, 2024 December 2024
NCT06447961 Not yet recruiting PSYLIVED: the Psychological Impacts of Living With an Inherited Colorectal Cancer Predisposition Syndrome June 15, 2024 August 1, 2026
NCT01199250 Not yet recruiting Biomarkers in Samples From Patients With Endometrial Cancer January 2100
NCT05909410 Not yet recruiting Perception About Benefits and Risks Related to Combined Hormonal Contraceptives Use in Patients With Lynch Syndrome July 1, 2023 September 1, 2023
NCT05963191 Not yet recruiting N/A CAD-EYE System for the Detection of Neoplastic Lesions in Patients With Lynch Syndrome October 2, 2023 October 2, 2025
NCT05495776 Recruiting Prospective Multicenter Registry Study to Assess the Frequency of Lynch Syndrome Among Patients With Colorectal Cancer August 1, 2022 December 31, 2028
NCT00508573 Recruiting Registry for Women Who Are At Risk Or May Have Lynch Syndrome May 2007 May 2029
NCT00582296 Recruiting Multi-Organ Screening Recommendations in Patients With Lynch Syndrome December 2004 December 2025
NCT00927680 Recruiting Familial Colorectal Cancer Registry in Hispanics July 2007 January 2026
NCT02000089 Recruiting Phase 3 The Cancer of the Pancreas Screening-5 CAPS5)Study January 6, 2014 December 2025
NCT02012699 Recruiting Integrated Cancer Repository for Cancer Research November 1, 2013 December 2099
NCT02359565 Recruiting Phase 1 Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma May 22, 2015 December 31, 2026
NCT02813824 Recruiting Phase 3 Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome November 14, 2017 December 15, 2027
NCT03050268 Recruiting Familial Investigations of Childhood Cancer Predisposition April 6, 2017 March 31, 2037
NCT03124212 Recruiting Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland April 1, 2017 September 30, 2024
NCT03303833 Recruiting The GEOLynch Cohort Study July 1, 2006 December 2030
NCT03702309 Recruiting Liquid Biopsy Evaluation and Repository Development at Princess Margaret August 3, 2017 July 6, 2024
NCT04095195 Recruiting Registry of Subjects at Risk of Pancreatic Cancer August 20, 2019 September 20, 2045
NCT04379999 Recruiting Early Phase 1 Atorvastatin ± Aspirin in Lynch Syndrome Syndrome September 10, 2018 December 31, 2024
NCT04407611 Recruiting N/A Scalable Communication Modalities for Returning Genetic Research Results March 6, 2023 December 2024
NCT04494945 Recruiting N/A Identifying and Caring for Individuals With Inherited Cancer Syndrome March 9, 2020 June 10, 2030
NCT04711434 Recruiting Phase 3 PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients November 1, 2020 December 31, 2025
NCT04791644 Recruiting Faecal Microbiota Characterization in Lynch Syndrome (LS) Patients With or Without Colorectal Neoplasia April 20, 2021 December 30, 2024
NCT04865601 Recruiting DNA Adductomics for Colorectal Cancer Investigation February 15, 2021 December 31, 2025
NCT05410977 Recruiting Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients, CORAL Study March 30, 2022 April 1, 2026
NCT05411718 Recruiting Phase 2 A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome March 21, 2023 November 30, 2025
NCT05419011 Recruiting Phase 2 Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome May 8, 2023 February 1, 2027
NCT05677048 Recruiting N/A Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention April 14, 2023 October 31, 2027
NCT05692596 Recruiting The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics October 6, 2022 August 2025
NCT05704010 Recruiting N/A Videocapsule Endoscopy in Lynch Syndrome November 1, 2018 December 31, 2026
NCT06163365 Recruiting Inherited Cancer Early Diagnosis (ICED) Study July 26, 2022 July 26, 2025
NCT06218433 Recruiting N/A Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study) April 10, 2023 December 31, 2034
NCT04920149 Recruiting Phase 2 Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome March 21, 2022 October 15, 2038
NCT04978350 Recruiting N/A Overcoming Barriers to the Uptake of Cascade Screening for Lynch Syndrome: Workbook Feasibility Study October 1, 2021 August 2024
NCT05078866 Recruiting Phase 1/Phase 2 Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients November 10, 2022 July 31, 2025
NCT05129605 Recruiting Prostate Cancer Genetic Risk Evaluation and Screening Study February 12, 2020 December 2040
NCT04508764 Terminated N/A Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome April 9, 2021 March 20, 2024
NCT04906382 Terminated Early Phase 1 Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer July 1, 2021 September 1, 2022
NCT02053805 Unknown status N/A Prostate Cancer Screening Among Men With High Risk Genetic Predisposition February 2014 June 2019
NCT04516083 Unknown status Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation December 21, 2019 June 30, 2021
NCT03744962 Unknown status MSI in Circulatory DNA of Endometrial Cancer November 10, 2018 December 23, 2020
NCT04909671 Unknown status N/A Evaluation of ArTificial Intelligence System (Gi-Genius) for adenoMa dEtection in Lynch Syndrome. September 13, 2021 December 1, 2023
NCT04778566 Withdrawn Evaluating the Cologuard Test for Use in Lynch Syndrome November 2021 September 2022
NCT04500548 Withdrawn Phase 1 Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study January 28, 2021 June 21, 2022
Disase is a (Disease Ontology)
DOID:225
Cross Reference ID (Disease Ontology)
GARD:9905
Cross Reference ID (Disease Ontology)
MESH:D003123
Cross Reference ID (Disease Ontology)
MIM:PS120435
Cross Reference ID (Disease Ontology)
NCI:C120083
Cross Reference ID (Disease Ontology)
ORDO:144
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:700064004
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0009405
Cross Reference ID (Disease Ontology)
UMLS_CUI:C1333990
Exact Synonym (Disease Ontology)
COCA 1
Exact Synonym (Disease Ontology)
Hereditary Defective Mismatch Repair syndrome
Exact Synonym (Disease Ontology)
Hereditary non-polyposis colon cancer
Exact Synonym (Disease Ontology)
Hereditary non-polyposis colon cancer syndrome
Exact Synonym (Disease Ontology)
Hereditary non-polyposis colorectal cancer
Exact Synonym (Disease Ontology)
Hereditary non-polyposis colorectal cancer syndrome
Exact Synonym (Disease Ontology)
Hereditary nonpolyposis colon cancer
Exact Synonym (Disease Ontology)
Hereditary nonpolyposis colon cancer syndrome
Exact Synonym (Disease Ontology)
hereditary nonpolyposis colorectal cancer
Exact Synonym (Disease Ontology)
Hereditary nonpolyposis colorectal cancer syndrome
Exact Synonym (Disease Ontology)
hereditary nonpolyposis colorectal neoplasm
Exact Synonym (Disease Ontology)
HNPCC - hereditary nonpolyposis colon cancer